Vision loss following high-dose proton-based radiotherapy for skull-base chordoma and chondrosarcoma

CONCLUSIONS: Despite the high radiotherapy dose delivered to patients with skull-base chordoma and chondrosarcoma, the rate of vision loss is low and no events occurred in those who received a maximum dose under 60GyRBE.PMID:33610625 | DOI:10.1016/j.radonc.2021.02.012

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - February 21, 2021 Category: Radiology Authors: Alexandra N De Leo Adam L Holtzman M W Ho Christopher G Morris Michael S Rutenberg Ronny L Rotondo James E Bates Daniel J Indelicato Dinesh Rao Mohammad Asa Hasan William M Mendenhall Source Type: research